Cargando…
The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer
BACKGROUND: The clinical use of patient-reported outcomes as compared to inflammatory biomarkers for predicting cancer survival remains a challenge in palliative care settings. We evaluated the role of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988985/ https://www.ncbi.nlm.nih.gov/pubmed/33757453 http://dx.doi.org/10.1186/s12885-021-08049-3 |
_version_ | 1783668872872722432 |
---|---|
author | Koyama, Nanako Matsumura, Chikako Shitashimizu, Yoshihiro Sako, Morito Kurosawa, Hideo Nomura, Takehisa Eguchi, Yuki Ohba, Kazuki Yano, Yoshitaka |
author_facet | Koyama, Nanako Matsumura, Chikako Shitashimizu, Yoshihiro Sako, Morito Kurosawa, Hideo Nomura, Takehisa Eguchi, Yuki Ohba, Kazuki Yano, Yoshitaka |
author_sort | Koyama, Nanako |
collection | PubMed |
description | BACKGROUND: The clinical use of patient-reported outcomes as compared to inflammatory biomarkers for predicting cancer survival remains a challenge in palliative care settings. We evaluated the role of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative scores (EORTC QLQ-C15-PAL) and the inflammatory biomarkers C-reactive protein (CRP), albumin (Alb), and neutrophil-lymphocyte ratio (NLR) for survival prediction in patients with advanced cancer. METHODS: This was an observational study in terminally ill patients with cancer hospitalized in a palliative care unit between June 2018 and December 2019. Patients’ data collected at the time of hospitalization were analyzed. Cox regression was performed to examine significant factors influencing survival. A receiver operating characteristic (ROC) analysis was performed to estimate cut-off values for predicting survival within 3 weeks, and a log-rank test was performed to compare survival curves between groups divided by the cut-off values. RESULTS: Totally, 130 patients participated in the study. Cox regression suggested that the QLQ-C15-PAL dyspnea and fatigue scores and levels of CRP, Alb, and NLR were significantly associated with survival time, and cut-off values were 66.67, 66.67, 3.0 mg/dL, 2.5 g/dL, and 8.2, respectively. The areas under ROC curves of these variables were 0.6–0.7. There were statistically significant differences in the survival curves between groups categorized using each of these cut-off values (p < .05 for all cases). CONCLUSION: Our findings suggest that the assessment of not only objective indicators for the systemic inflammatory response but also patient-reported outcomes using EORTC QLQ-C15-PAL is beneficial for the prediction of short-term survival in terminally ill patients with cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08049-3. |
format | Online Article Text |
id | pubmed-7988985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79889852021-03-25 The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer Koyama, Nanako Matsumura, Chikako Shitashimizu, Yoshihiro Sako, Morito Kurosawa, Hideo Nomura, Takehisa Eguchi, Yuki Ohba, Kazuki Yano, Yoshitaka BMC Cancer Research Article BACKGROUND: The clinical use of patient-reported outcomes as compared to inflammatory biomarkers for predicting cancer survival remains a challenge in palliative care settings. We evaluated the role of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative scores (EORTC QLQ-C15-PAL) and the inflammatory biomarkers C-reactive protein (CRP), albumin (Alb), and neutrophil-lymphocyte ratio (NLR) for survival prediction in patients with advanced cancer. METHODS: This was an observational study in terminally ill patients with cancer hospitalized in a palliative care unit between June 2018 and December 2019. Patients’ data collected at the time of hospitalization were analyzed. Cox regression was performed to examine significant factors influencing survival. A receiver operating characteristic (ROC) analysis was performed to estimate cut-off values for predicting survival within 3 weeks, and a log-rank test was performed to compare survival curves between groups divided by the cut-off values. RESULTS: Totally, 130 patients participated in the study. Cox regression suggested that the QLQ-C15-PAL dyspnea and fatigue scores and levels of CRP, Alb, and NLR were significantly associated with survival time, and cut-off values were 66.67, 66.67, 3.0 mg/dL, 2.5 g/dL, and 8.2, respectively. The areas under ROC curves of these variables were 0.6–0.7. There were statistically significant differences in the survival curves between groups categorized using each of these cut-off values (p < .05 for all cases). CONCLUSION: Our findings suggest that the assessment of not only objective indicators for the systemic inflammatory response but also patient-reported outcomes using EORTC QLQ-C15-PAL is beneficial for the prediction of short-term survival in terminally ill patients with cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08049-3. BioMed Central 2021-03-23 /pmc/articles/PMC7988985/ /pubmed/33757453 http://dx.doi.org/10.1186/s12885-021-08049-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Koyama, Nanako Matsumura, Chikako Shitashimizu, Yoshihiro Sako, Morito Kurosawa, Hideo Nomura, Takehisa Eguchi, Yuki Ohba, Kazuki Yano, Yoshitaka The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer |
title | The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer |
title_full | The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer |
title_fullStr | The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer |
title_full_unstemmed | The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer |
title_short | The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer |
title_sort | role of eortc qlq-c15-pal scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988985/ https://www.ncbi.nlm.nih.gov/pubmed/33757453 http://dx.doi.org/10.1186/s12885-021-08049-3 |
work_keys_str_mv | AT koyamananako theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT matsumurachikako theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT shitashimizuyoshihiro theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT sakomorito theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT kurosawahideo theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT nomuratakehisa theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT eguchiyuki theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT ohbakazuki theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT yanoyoshitaka theroleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT koyamananako roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT matsumurachikako roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT shitashimizuyoshihiro roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT sakomorito roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT kurosawahideo roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT nomuratakehisa roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT eguchiyuki roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT ohbakazuki roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer AT yanoyoshitaka roleofeortcqlqc15palscoresandinflammatorybiomarkersinpredictingsurvivalinterminallyillpatientswithcancer |